News & Events about Simulations Plus Inc.
Simulations Plus (NASDAQ:SLP Get Rating) updated its FY 2023 earnings guidance on Wednesday. The company provided earnings per share guidance of $0.63-$0.67 for the period, compared to the consensus earnings per share estimate of $0.65. The company issued revenue guidance of $59.30 million-$62.00 ...
Simulations Plus, Inc. (NASDAQ:SLP Get Rating) Director Walter S. Woltosz sold 20,000 shares of the companys stock in a transaction that occurred on Friday, February 24th. The shares were sold at an average price of $38.04, for a total value of $760,800.00. Following the completion of the sale, the ...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates 44th Annual Institutional Investors Conference, scheduled...
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has released DILIsym version X (DSX) Beta, the latest version of its flagship quantitative...